Total: 701

    Systematic review of nonpharmacological analgesic interventions for common needle‐related procedure in newborn infants and development of evidence‐based clinical guidelines

    Acta paediatr. (1921); 106 (6), 2017
    The aim of this literature review was to develop clinical guidelines for the prevention and control of needle‐related pain in newborn infants. The guidelines were developed by the Italian Society of Neonatology, using the Grading of Recommendations, Assessment, Development and Evaluation approach, base...

    Risk reduction of cognitive decline and dementia: WHO guidelines

    The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. Worldwide, around 50 million people have dementia and, with one new case every three seconds, the num...

    Recommendations on digital interventions for health system strengthening: WHO guideline

    The key aim of this guideline is to present recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits, harms, acceptability, feasibility, resource use and equity consi...

    Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO

    Pediatr. nephrol; 28 (3), 2013
    The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on glomerulonephritis (GN) is intended to assist the practitioner caring for patients with GN. Two chapters of this guideline focus specifically on nephrotic syndrome in children. Guideline development followed a thoro...

    2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis

    Mod. rheumatol; 29 (1), 2019
    The Japan Research Committee for Intractable Vasculitis has fully revised the clinical practice guidelines (CPG) for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) to improve and standardize the medical treatment of the disease in Japan. The previous CPG was published i...

    Suspected neurological conditions: recognition and referral - update information

    This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation. This guideline includes recommendations for: people aged 16 and...

    Neuropathic pain in adults: the pharmacological management in non-specialist settings - update information

    This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participati...

    Chronic obstructive pulmonary disease in over 16s: diagnosis and management - update information

    This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve q...

    End of life care for infants, children and young people with life-limiting conditions: planning and management - update information

    This guideline covers the planning and management of end of life and palliative care in for infants, children and young people (aged 0–17 years) with life-limiting conditions. It aims to involve children, young people and their families in decisions about their care, and improve the support that is ava...

    Multiple sclerosis: Management of multiple sclerosis in primary and secondary care - update information

    This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment. This guideline includes recommendations on: diagno...